peer-reviewed"Final published version uploaded to ULIR on the 16/12/2021"no abstract availabl
The NNRTI efavirenz has long been one of the most frequently employed antiretroviral drugs in the mu...
Efavirenz is a highly effective HIV-1 antiretroviral; however, it is also frequently associated with...
Substance-use disorder represents a frequently hidden non-communicable chronic disease. Patients wit...
OBJECTIVE: Although remdesivir (GS-5734) has recently demonstrated clinical benefits against the pan...
Objective: Although remdesivir (GS-5734) has recently demonstrated clinical benefits against the pan...
Background: To summarize specific adverse effects of remdesivir, hydroxychloroquine, and lopinavir/r...
As the world races to find the solution to the COVID-19 pandemic, an investigational agent which has...
Background: Efavirenz is part of the first-line treatment for HIV patients including South Africa wi...
peer reviewedThis review gives an up-to-date account of the current state of research on neuropsychi...
Introduction: Efavirenz is a potent, safe and tolerable non-nucleoside reverse transcriptase inhibit...
The emergence of the novel beta coronavirus SARS-CoV-2 and the ensuing COVID-19 pandemic has generat...
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) primarily affects the respiratory t...
Introduction The coronavirus disease 2019 (COVID-19) first emerged in December 2019 in Wuhan City, H...
OBJECTIVE: The objective of this selective EBM review is to determine whether or not Etravirine (ETR...
Efavirenz is associated with neuropsychiatric side effects. The consequences of using efavirenz in h...
The NNRTI efavirenz has long been one of the most frequently employed antiretroviral drugs in the mu...
Efavirenz is a highly effective HIV-1 antiretroviral; however, it is also frequently associated with...
Substance-use disorder represents a frequently hidden non-communicable chronic disease. Patients wit...
OBJECTIVE: Although remdesivir (GS-5734) has recently demonstrated clinical benefits against the pan...
Objective: Although remdesivir (GS-5734) has recently demonstrated clinical benefits against the pan...
Background: To summarize specific adverse effects of remdesivir, hydroxychloroquine, and lopinavir/r...
As the world races to find the solution to the COVID-19 pandemic, an investigational agent which has...
Background: Efavirenz is part of the first-line treatment for HIV patients including South Africa wi...
peer reviewedThis review gives an up-to-date account of the current state of research on neuropsychi...
Introduction: Efavirenz is a potent, safe and tolerable non-nucleoside reverse transcriptase inhibit...
The emergence of the novel beta coronavirus SARS-CoV-2 and the ensuing COVID-19 pandemic has generat...
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) primarily affects the respiratory t...
Introduction The coronavirus disease 2019 (COVID-19) first emerged in December 2019 in Wuhan City, H...
OBJECTIVE: The objective of this selective EBM review is to determine whether or not Etravirine (ETR...
Efavirenz is associated with neuropsychiatric side effects. The consequences of using efavirenz in h...
The NNRTI efavirenz has long been one of the most frequently employed antiretroviral drugs in the mu...
Efavirenz is a highly effective HIV-1 antiretroviral; however, it is also frequently associated with...
Substance-use disorder represents a frequently hidden non-communicable chronic disease. Patients wit...
DOI
Add to ORKG